Rotations 2.0

Rotations 2.0 Episode 71 Squamous Cell Carcinoma

Todd Fredricks DO MSS Season 2 Episode 71

Use Left/Right to seek, Home/End to jump to start or end. Hold shift to jump forward or backward.

0:00 | 39:24

Send us Fan Mail

Episode 71 Squamous Cell Carcinoma

Shoot me any comments or questions @Rotation2ptoh  on X

Intro Music: KI Instrumental (Rock Celtic) by Lyrium-2025

Outro Music: Fragile Beauty by Alex Grohl

Courtesy of Pixabay under Creative Commons non-commercial use.

Produced by: Todd Fredricks DO MSS 

Edited by: Todd Fredricks DO MSS

Answers for Episode 70 Basal Cell Carcinoma 

Question 1 

A 72-year-old patient presents with a 0.8-cm pearly papule with telangiectasias on the nasal ala that intermittently bleeds. A shave biopsy confirms basal cell carcinoma. Which risk category best applies to this lesion based on NCCN high-risk features summarized in the article?

B. High-risk basal cell carcinoma

Question 2 

A 66-year-old patient has metastatic basal cell carcinoma (mBCC) and is started on vismodegib, a Hedgehog pathway inhibitor. Which of the following best matches the outcomes reported in the article from the ERIVANCE BCC trial for patients with mBCC?

C. ORR 48%, median PFS 9.5 months, OS ~33 months

Question 3 

A patient with advanced BCC has progressed after a Hedgehog pathway inhibitor and is being considered for chemotherapy. According to the article, which regimen corresponds to a retrospective study reporting a partial response rate of 43% and median PFS of 6 months in advanced BCC?

D. Cisplatin 50 mg/m² IV on days 1 and 8 + cyclophosphamide 600 mg/m² IV 

van Zuuren, Esther J., Bernd W. M. Arents, Mirelle M. D. van der Linden, Sofieke Vermeulen, Zbys Fedorowicz, and Jerry Tan. “Rosacea: New Concepts in Classification and Treatment.” American Journal of Clinical Dermatology 22 (2021): 457–465. https://doi.org/10.1007/s40257-021-00595-7. 

Rotations  2.0 is copyrighted. But you can use any content from the podcast for non-commercial purposes under Creative Commons….BUT, BUT, BUT, you must cite Rotations 2.0 and Todd Fredricks DO MSS as the source of the material AND AND AND you cannot alter or edit the content in any manner without expressed permission of Todd Fredricks DO MSS.

Rotations 2.0 is made possible by the generous understanding and accommodation of my beloved institution, Ohio University. The comments and ideas expressed on Rotations 2.0 are that of the content creators alone and may not reflect official policy or the opinion of the Ohio University, the State of Ohio, or the US Government or any other state, person or governmental agency.

Listeners interested in specifics from the paper authors should contact them directly through their respective institutions.

Any therapeutic ideas discussed should not be taken as any kind of medical advice or recommendations by the content creators and the content creators are not offering medical advice but discussing topics from an academic perspective. Listeners seeking advice about any medical care or decision-making should consult their own physician or medical provider and the content creators of Rotations 2.0 assume no liability for any listener's care or decision-making stemming from the topics discussed on Rotations 2.0.